LOTUFLO-D CAPSULES 0.5 MG/0.4 MG
Product details
Registration number: SIN16678P
Classification: Prescription Only
Active ingredients:
- Dutasteride
- Tamsulosin hydrochloride
Strength:
- 0.5 mg
- 0.4 mg
Dosage form: CAPSULE
Route: ORAL
Registrant: LOTUS INTERNATIONAL PTE. LTD.
ATC code: G04CA52
HSA approval date: 17 January 2023
Manufacturer(s):
- LABORATORIOS LEÓN FARMA, SA (DP intermediate dutasteride capsule and final DP)
- S.C. ZENTIVA S.A. (DP Intermediate, Tamsulosin pellet)
- LABORATORIOS LICONSA, S.A (primary and secondary packager)
Manufacturing country/countries: SPAIN; ROMANIA
What are the HSA registration number and classification for LOTUFLO-D CAPSULES 0.5 MG/0.4 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16678P
Classification: Prescription Only
What active ingredients and strength are recorded for LOTUFLO-D CAPSULES 0.5 MG/0.4 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Dutasteride
- Tamsulosin hydrochloride
Strength:
- 0.5 mg
- 0.4 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for LOTUFLO-D CAPSULES 0.5 MG/0.4 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for LOTUFLO-D CAPSULES 0.5 MG/0.4 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: LOTUS INTERNATIONAL PTE. LTD.
Which manufacturers and countries are listed for LOTUFLO-D CAPSULES 0.5 MG/0.4 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- LABORATORIOS LEÓN FARMA, SA (DP intermediate dutasteride capsule and final DP)
- S.C. ZENTIVA S.A. (DP Intermediate, Tamsulosin pellet)
- LABORATORIOS LICONSA, S.A (primary and secondary packager)
Manufacturing country/countries: SPAIN; ROMANIA
Where can I look up LOTUFLO-D CAPSULES 0.5 MG/0.4 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16678P or the exact product name LOTUFLO-D CAPSULES 0.5 MG/0.4 MG. The general register link does not preselect this product.
What are the source dates for this LOTUFLO-D CAPSULES 0.5 MG/0.4 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this LOTUFLO-D CAPSULES 0.5 MG/0.4 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16678P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)